DILAX
Price
$13.83
Change
-$0.08 (-0.58%)
Updated
May 7 closing price
Net Assets
168.18M
VTISX
Price
$146.71
Change
-$0.34 (-0.23%)
Updated
May 7 closing price
Net Assets
469.79B
Ad is loading...

DILAX vs VTISX

Header iconDILAX vs VTISX Comparison
Open Charts DILAX vs VTISXBanner chart's image
Davis International A
Price$13.83
Change-$0.08 (-0.58%)
VolumeN/A
Net Assets168.18M
Vanguard Total Intl Stock Idx Instl Sel
Price$146.71
Change-$0.34 (-0.23%)
VolumeN/A
Net Assets469.79B
DILAX vs VTISX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DILAX vs. VTISX commentary
May 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DILAX is a StrongBuy and VTISX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTISX has more cash in the bank: 470B vs. DILAX (168M). VTISX pays higher dividends than DILAX: VTISX (3.07) vs DILAX (2.15). DILAX was incepted earlier than VTISX: DILAX (18 years) vs VTISX (9 years). DILAX (1.17) is less costly to investors than VTISX (0.05). DILAX is a more actively managed with annual turnover of: 23.00 vs. VTISX (3.00). DILAX has a lower initial minimum investment than VTISX: DILAX (1000) vs VTISX (3000000000). DILAX annual gain was more profitable for investors over the last year : 14.70 vs. VTISX (8.11). VTISX return over 5 years is better than : 49.17 vs. DILAX (33.56).
DILAXVTISXDILAX / VTISX
Total Expense Ratio1.130.052,404%
Annual Report Gross Expense Ratio1.170.052,489%
Fund Existence18 years9 years-
Gain YTD6.96110.27168%
Front Load5%N/A-
Min. Initial Investment100030000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets168M470B0%
Annual Yield % from dividends2.153.0770%
Returns for 1 year14.708.11181%
Returns for 3 years52.6722.53234%
Returns for 5 years33.5649.1768%
Returns for 10 years34.14N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTGX43.091.08
+2.57%
Protagonist Therapeutics
GLSI9.440.06
+0.64%
Greenwich LifeSciences
RNR248.140.57
+0.23%
RenaissanceRe Holdings Ltd
PLPC133.680.01
+0.01%
Preformed Line Products Company
RSLS0.35-0.09
-20.54%
ReShape Lifesciences Inc